Idiopathic pulmonary hemosiderosis
Other Names for this Disease
- Hemosiderosis, pulmonary, with deficiency of gamma-a globulin
- Alveolar hypoventilation syndrome
- Pulmonary hemosiderosis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
The treatment of idiopathic pulmonary hemosiderosis is aimed at managing acute crises and providing long-term therapy. Acute therapies may include oxygen supplementation, blood transfusion, supportive respiratory therapy, mechanical ventilatory support, extracorporeal membrane oxygenation and immunosuppressive therapy. The use of immunosuppressive therapy for long-term management remains controversial.
More detailed information about the treatment of idiopathic pulmonary hemosiderosis can be accessed through eMedicine. Click on the following links to learn more about Treatment & Management and Medications.
Last updated: 7/6/2011
- Napchan GD, Talmaciu I. Hemosiderosis. eMedicine. 2009; http://emedicine.medscape.com/article/1002002-overview. Accessed 7/6/2011.
- ClinicalTrials.gov lists trials that are studying or have studied Idiopathic pulmonary hemosiderosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.